Transfusion-Dependent β-Thalassemia (TDT) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

β-thalassemia is typically a result of a monogenic disorder, primarily caused by a decrease or absence in the synthesis of the β-globin chain. This particular chain is vital to adult hemoglobin (HbA, α2β2). Consequently, an imbalance occurs between α and β chains, accumulating unattached α-globin chains. These excess α-globin chains form insoluble Hemi-chromes within erythrocyte precursor cells, causing damage to the erythrocyte membrane. This damage, in turn, triggers severe intramedullary erythrocyte apoptosis, referred to as ineffective erythropoiesis (IE). As a result, red blood cells (RBCs) experience a significantly shortened lifespan due to extra-medullary hemolysis, leading to severe anemia. The most severe manifestation of this condition, known as transfusion-dependent β-thalassemia (TDT), is characterized by profound anemia. To maintain adequate hemoglobin levels, individuals with TDT require lifelong and regular blood transfusions. However, these transfusions pose a con...